Fred's Inc. (FRED) Drops 11.55% on February 04

Equities Staff |

Fred's Inc. (FRED) was one of the Russell 2000's biggest losers for Thursday February 04 as the stock slid 11.55% to $13.32, a loss of $-1.74 per share. Starting at an opening price of $14.76 a share, the stock traded between $12.91 and $15.07 over the course of the trading day. Volume was 292,824 shares over 2,869 trades, against an average daily volume of 211,995 shares and a total float of 37.35 million.

The losses send Fred's Inc. down to a market cap of $497.44 million. In the last year, Fred's Inc. has traded between $20.05 and $11.27, and its 50-day SMA is currently $15.69 and 200-day SMA is $15.71.

Fred's Inc, and subsidiaries sells general merchandise through its retail discount stores and full service pharmacies.

Fred's Inc. is based out of Memphis, TN and has some 9,148 employees. Its CEO is Jerry A. Shore.

For a complete fundamental analysis analysis of Fred's Inc., check out’s Stock Valuation Analysis report for FRED. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…